Clinical Trial Update: An Open-label Extension Trial of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures [Phase 2]

View source ↗

Summary

An open-label extension of CVL-865 evaluated as adjunctive therapy for focal onset seizures in a Phase 2 study; the trial was terminated and results have been p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Focal Onset Seizures

Drugs mentioned

• CVL-865

Snippet

Sponsor: AbbVie | Conditions: Seizures | Phase 2 | Status: TERMINATED | Results posted: 2025-12-11